Search for
Iron Studies (Iron, TIBC, Transferrin Saturation)
Anemia
Report in 4Hrs
At Home
Fasting Required
Details
Evaluate causes of fatigue, pallor, hair loss, or restless leg syndrome
₹249₹660
62% OFF
Iron Studies (Iron, TIBC, Transferrin Saturation)
- Why is it done?
- Tests measure iron levels in blood and iron transport capacity to assess iron metabolism and detect iron-related disorders
- Diagnose iron deficiency anemia (low iron levels causing reduced oxygen-carrying capacity)
- Detect iron overload conditions such as hemochromatosis and secondary iron overload disorders
- Evaluate anemia of unclear etiology or persistent fatigue, weakness, and shortness of breath
- Monitor patients with chronic kidney disease, rheumatoid arthritis, or malabsorption syndromes
- Screen for hereditary hemochromatosis, particularly in patients with family history or elevated liver enzymes
- Assess efficacy of iron supplementation or phlebotomy therapy in patients undergoing treatment
- Evaluate inflammation or chronic disease affecting iron metabolism
- Normal Range
- Serum Iron: 60-170 mcg/dL (10.7-30.4 mcmol/L) for males; 50-150 mcg/dL (8.9-26.9 mcmol/L) for females. Values vary by laboratory and can fluctuate throughout the day.
- Total Iron-Binding Capacity (TIBC): 250-450 mcg/dL (45-81 mcmol/L). Reflects total transferrin available to bind and transport iron.
- Transferrin Saturation: 20-50%. Calculated as (serum iron ÷ TIBC) × 100. Represents percentage of transferrin binding sites occupied by iron.
- Interpretation Guide:
- Normal: All three parameters within reference ranges indicate adequate iron stores and appropriate iron metabolism
- Low iron with elevated TIBC and low transferrin saturation: Indicative of iron deficiency
- High iron with low or normal TIBC and elevated transferrin saturation: Suggests iron overload
- Low iron with low TIBC: May indicate inflammation, chronic disease, or liver dysfunction
- Interpretation
- Iron Deficiency Anemia: Characterized by low serum iron (<60 mcg/dL), elevated TIBC (>450 mcg/dL), and low transferrin saturation (<20%). Indicates insufficient iron for hemoglobin production.
- Iron Overload (Hemochromatosis): Marked by elevated serum iron (>170 mcg/dL), low or normal TIBC (<250 mcg/dL), and elevated transferrin saturation (>50-60%). Can lead to organ damage if untreated.
- Anemia of Chronic Disease: Shows low serum iron, low TIBC, and variable transferrin saturation. Associated with chronic infections, malignancies, autoimmune disorders, or kidney disease.
- Secondary Iron Overload: Results from repeated transfusions or hemolysis. Shows elevated iron and low TIBC similar to primary hemochromatosis.
- Factors Affecting Results:
- Diurnal variation: Serum iron can vary by 20-40% throughout the day (higher in morning)
- Inflammation: Elevates hepcidin, reducing serum iron and TIBC in acute phase response
- Medications: Estrogen increases iron; NSAIDs may cause GI bleeding and iron loss; oral contraceptives elevate transferrin
- Recent transfusions: Artificially elevate serum iron levels for 24-48 hours
- Time of collection: Morning fasting samples preferred for consistency and reproducibility
- Clinical Significance:
- Pattern recognition: Combined interpretation of all three parameters provides diagnostic clarity better than individual values
- Transferrin saturation >45% warrants investigation for hemochromatosis even if serum iron is borderline
- Repeated low iron studies differentiate true deficiency from acute inflammation-related changes
- Associated Organs
- Primary Organs Involved:
- Bone marrow: Site of red blood cell production; iron deficiency impairs hemoglobin synthesis, resulting in microcytic anemia
- Liver: Primary organ for iron storage, metabolism, and hepcidin production; iron overload causes cirrhosis, fibrosis, and hepatocellular carcinoma
- Heart: Excess iron causes restrictive or dilated cardiomyopathy and conduction abnormalities
- Pancreas: Iron deposition causes diabetes mellitus and pancreatic insufficiency
- Pituitary gland: Iron accumulation impairs hormone production affecting growth and reproductive function
- Gastrointestinal tract: Absorbs iron; disorders affecting absorption cause deficiency; genetic mutations in iron transport genes affect levels
- Associated Medical Conditions:
- Hereditary hemochromatosis (HFE mutations): Most common cause of iron overload in Caucasians; progressive organ damage if untreated
- Thalassemia major: Chronic hemolysis and transfusion requirements lead to secondary iron overload
- Sickle cell disease: Hemolysis and transfusions cause secondary hemochromatosis
- Celiac disease: Malabsorption leads to iron deficiency despite adequate intake
- Chronic kidney disease: Reduced erythropoietin production and iron loss during dialysis cause deficiency
- Inflammatory bowel disease: Chronic bleeding and malabsorption cause iron deficiency
- Pregnancy and postpartum: Increased iron demands and blood loss during delivery increase deficiency risk
- Chronic liver disease: Impaired iron metabolism and cirrhosis risk with overload
- Potential Complications of Abnormal Results:
- Iron deficiency: Fatigue, dyspnea, impaired cognition in children, increased infection risk, restless leg syndrome
- Iron overload: Hepatic cirrhosis, hepatocellular carcinoma, cardiac arrhythmias, heart failure, diabetes mellitus, joint arthropathy, hypogonadism
- Oxidative stress: Both deficiency and excess impair normal cellular function through reactive oxygen species generation
- Follow-up Tests
- Based on Low Iron/Iron Deficiency:
- Ferritin levels: Marker of iron stores; low levels confirm iron deficiency (typically <30 ng/mL; <10 ng/mL highly specific for deficiency)
- Complete blood count (CBC): Reveals degree of anemia, RBC indices (microcytic hypochromic pattern in iron deficiency)
- Reticulocyte count: Assesses bone marrow response to iron supplementation; rising levels indicate effective treatment
- Soluble transferrin receptor (sTfR): More specific for iron deficiency; rises as storage iron depletes; helps differentiate from anemia of chronic disease
- Peripheral blood smear: Visualizes RBC morphology; shows microcytic hypochromic cells in deficiency
- Gastrointestinal evaluation: Upper and lower endoscopy if cause of deficiency unclear; investigate for bleeding or malabsorption
- Celiac serology: Tissue transglutaminase (tTG-IgA) and endomysial antibodies to screen for malabsorption
- Based on High Iron/Iron Overload:
- Ferritin levels: Elevated ferritin (>300 ng/mL males, >200 ng/mL females) indicates iron storage increase; requires further investigation
- Genetic testing: HFE gene mutations (C282Y and H63D) for hereditary hemochromatosis diagnosis
- Liver function tests: AST, ALT, bilirubin, albumin to assess hepatic iron-related damage and cirrhosis
- MRI imaging: Cardiac MRI (T2*) and hepatic iron quantification to assess organ iron deposition and risk
- Echocardiography: Evaluates cardiac function in iron overload; screens for cardiomyopathy and arrhythmias
- Glucose screening: Fasting glucose and HbA1c for iron-induced diabetes mellitus
- Liver ultrasound or elastography: Assesses cirrhosis and portal hypertension development
- Monitoring During Treatment:
- Iron studies: Repeat every 4-12 weeks during iron supplementation to assess response and prevent overtreatment
- Ferritin and transferrin saturation: Monthly monitoring during phlebotomy for hemochromatosis to maintain therapeutic target ranges
- CBC and reticulocyte count: Assess treatment efficacy and anemia resolution
- Liver function tests: Every 6-12 months in iron overload conditions to monitor for progressive damage
- Fasting Required?
- Fasting Status: YES - Fasting is required for accurate results
- Duration: 8-12 hours overnight fasting before blood collection recommended
- Special Instructions:
- Morning collection preferred: Blood should be drawn in early morning (7-9 AM) to minimize diurnal variation in iron levels
- Nothing by mouth: No food or beverages except water for 8-12 hours before test; high-carbohydrate meals can affect iron absorption and measurements
- Consistent timing: Collect tests at same time of day on repeat draws for reliability in monitoring treatment
- Medications to Avoid or Disclose:
- Iron supplements: Hold iron supplementation for 24 hours before test to obtain baseline levels; inform laboratory if taking supplements
- Oral contraceptives: Increase transferrin and may elevate iron; continue as prescribed but notify laboratory
- Estrogen therapy: May elevate serum iron; disclose use to interpreting physician
- NSAIDs: May cause GI bleeding affecting results; continue if medically necessary but report to physician
- Tetracyclines and quinolones: Decrease iron absorption; space 2 hours from iron-containing foods/supplements
- Proton pump inhibitors: Reduce gastric acid and iron absorption; continue as prescribed and report to lab
- Additional Patient Preparation:
- Minimize stress: Avoid strenuous exercise 24 hours before test; physical stress can cause temporary iron fluctuations
- Avoid caffeine: Caffeine affects iron absorption; abstain for several hours before test
- Adequate hydration: Drink water throughout the fasting period; dehydration concentrates serum iron artificially
- Recent transfusions: Disclose within past 48 hours; blood transfusions artificially elevate iron levels
- Report recent illness: Fever and acute infection affect iron studies; schedule test 1-2 weeks after acute illness resolution
How our test process works!

